Immunostimulatory viral RNA oligonucleotides

Details for Australian Patent Application No. 2005230938 (hide)

Owner Coley Pharmaceutical GmbH Coley Pharmaceutical Group, Inc.

Inventors Lipford, Grayson B.; Forsbach, Alexandra

Agent Davies Collison Cave

Pub. Number AU-A-2005230938

PCT Pub. Number WO2005/097993

Priority 60/545,988 19.02.04 US

Filing date 18 February 2005

Wipo publication date 20 October 2005

International Classifications

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 31/7125 (2006.01) - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/097993 Priority application(s): WO2005/097993

20 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005230943-F-treatment of titanium materials

2005230936-Base specific cleavage of methylation-specific amplification products in combination with mass analysis